INTELLIA THERAPEUTICS INC (NTLA) Institutional Ownership

NTLA is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $186.01M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is ARK Invest, which reported ownership valued at approximately $186.01M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, ARK Invest's NTLA position is now estimated to be worth approximately $220.54M, representing an estimated gain of +18.56% since the filing period.

Major shareholders tracked on this page include ARK Invest, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional holding trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward INTELLIA THERAPEUTICS INC (NTLA).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$186,008,54514,509,247
Q4 20252$142,761,41315,880,024
Q3 20252$217,086,97012,570,178
Q2 20252$128,456,99713,694,776
Q1 20251$92,508,31913,011,015
Q4 20242$147,325,10812,635,086
Q3 20241$251,849,29612,255,440
Q2 20242$260,379,86511,634,489
Q1 20241$302,315,16110,989,282
Q4 20232$347,965,96511,425,846
Q3 20231$314,575,6389,948,629
Q2 20231$388,467,4849,525,931